ChemoCentryx
CCXI
#3708
Rank
NZ$6.64 B
Marketcap
NZ$92.46
Share price
0.00%
Change (1 day)
38.72%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.36. In 2021 the company made an earnings per share (EPS) of NZ-$3.36 a decrease over its 2020 EPS that were of NZ-$1.44.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-16.36%
2021NZ-$3.36133.33%
2020NZ-$1.44-16.49%
2019NZ-$1.7327.63%
2018NZ-$1.35-305.41%
2017NZ$0.66-142.53%
2016NZ-$1.55-19.44%
2015NZ-$1.92-0%
2014NZ-$1.9213.68%
2013NZ-$1.69-16.67%
2012NZ-$2.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.53-562.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.35-140.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.35-288.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.85-958.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$10.10-400.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-166.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.07-340.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.69-269.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.12-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel